Company Insight

wek-tec offers two non-invasive and up to absolute sterilization methods:

Main image credit: 

#1: Intense UV pulses fully sterilize clear-packed clear liquids.

It was proven on our PL system by Baxter Corp. with UV resistant spores of B. Pumilos: 

Clarifications to the energy chart below:
 
the effectiveness of Pulsed UV light increases with its power from identical to the continuous UVC light by low pressure Mercury vapor lamps to turning on accelerated DNA damages possible only for the intense UV pulses. 

Further right on the power scale in w/cm² starts the PUVD region where the applied power of UV and also of the visible light pulses physically disintegrate bacteria and spores. 

For this process to happen, UV and light pulses have to be very short, intense and rapid. 

It makes it possible to sterilize vaccines in vials.

wek-tec offers to check sterilization of your products with our PUV R&D systems: 
Data obtained during evaluation of your cases will allow to construct full-scale production PL sterilization tunnels for vials or for other use.

This method and PUV tunnel designs are wek-tec`s IP.

#2: non-invasive sterilization by Strong Pulsed Electrical Fields

Of various liquids and creams with our multi-parameter PEF pilot system available for custom process development supported by our local bio-lab:

The PEF pilot has the industry broadest changeable pulse parameters, operational convenience and safety:  

  • Pulse rates from 4Hz to 500Hz;  
  • Pulse are positive rectangular;  
  • Pulse lengths from 2µs to 50µs; 
  • Pulse fronts are ca. 1 µs,  
  • Pulse flatness ca. 5%; 
  • Electric fields 5kV/cm to 50kV/cm; 
  • selectable pulsing time  from 1s to 9h; 
  • 25kV 2kW pulser, up to 10kW options;  
  • overcurrent protection is build-in; 
  • scope is outside  or build-in;
  • in R&D changing from flat to coax chambers:  1min.;
  • convenient, simple to maintain, safe.

PEF sterilizes by stretching bacteria up to its ruptures with electrical fields 20-50kV/cm delivered by sharp square pulses as shown below for 25kV 50µs pulses:

More on process details is here.
PEF pilot brochure available here.

The PEF pilot can be delivered in one of two versions: 
 
1: for R&D: 1 
x PEF chamber for solids & creams and 1x coax PEF chamber for liquids;  
2: for pilot production:  
two in line coaxial chambers at same or different optimally enhanced pulsing using batch or direct flow through processing.

Both have easy to use reliable analogue control panel:

This PEF method and pilot designs are wek-tec`s IP.

The new promising method from wek-tec for UV sanitation or nutrient modifications of powders:

This lab R&D Vortex type system shown below provides physically only possible full UV exposure of each powder particle  by moving powders in the Nitrogen enriched turbulent air “vortex” flow in a cylindrical chamber around a long UV lamp in its centre.  It can be used for either:  

  1. to sanitize powder particles with UVC lamp lines.   
  2. with UVC, UVB or UVA to modify powder nutrient properties.  

Note: some powders have physical limitations for higher than 2 logs reductions with UV light.  

Our UV tunnel for powders has been designed for up to 100kg/h for a flow-through sanitation or powders photo-chemical modifications. It is for further adjustments in line with per data from evaluation of customers powder on our Vortex.  
This method and the tunnel design are IP of wek-tec.  

Please, send us your requirements along with your full affiliation via e-mail at info@wek-tec.de

wek-tec e. K. looks for an industrial partner to mutually benefit from  our IP.

Contact information

wek-tec e. K. 
Kronenstr.3 
D-78244 Gottmadingen 

Tel.: +49 (0)17270844 37 
Email: info@wek-tec.de 
Web: www.wek-tec.de

Go to article: Home | Pathbreakers: The journey of first genericsGo to article: Editor's letterGo to article: ContentsGo to article: wek-tec Company InsightGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: VeevaGo to article: In DepthGo to article: Pathbreakers: The journey of first genericsGo to article: Managed access programmes: Reaching patients in needGo to article: Insulin pricing in flux as major pharma players take actionGo to article: As RSV vaccine approvals loom, regulators need to devise vaccination strategiesGo to article: Build API facilities in Central and Eastern Europe to fix drug shortages, says report Go to article: CfPIEGo to article: BEA TechnologiesGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: The state of cybersecurity in 2023Go to article: The history of cybersecurityGo to article: The impact of cybersecurity on the pharmaceutical industryGo to article: Case studies: cybersecurity in the pharmaceutical industryGo to article: Latest news: cybersecurity in pharma Go to article: Q&A with GlobalData thematic analystGo to article: Key cybersecurity trends in PharmaGo to article: Cybersecurity in pharma: Securing the future Go to article: Deal activity related to cybersecurity in the pharmaceutical industry since 2018Go to article: Cybersecurity hiring trends in the global pharmaceutical industry since 2020Go to article: Cybersecurity patent applications in the global pharma industry since 2020Go to article: Mentions of cybersecurity in pharma industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue